Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Therapy areas
Infectious diseases
Infectious diseases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Infectious diseases
Exclusive: Trump to order drive for improved flu vaccine ...
Firstwordpharma News
-
July 16, 2019
Infectious diseases
Johnson & Johnson to initiate late-stage study of investigational tetravalent HIV vaccine this year
Infectious diseases
Johnson & Johnson to initiate late-stage study of investigational tetravalent HIV vaccine this year
Infectious diseases
Tanzania: HIV Vaccine Trial One Step Up ...
Infectious diseases
NIH launches large TB prevention trial for people exposed to multidrug-resistant TB
Infectious diseases
Dynavax Announces First Patient Enrolled in Study of HEPLISAV-B [Hepatitis B...
Firstwordpharma News
-
May 2, 2019
0
Infectious diseases
On-chip drug screening for identifying antibiotic interactions in eight hours ...
Firstwordpharma News
-
April 19, 2019
0
Infectious diseases
Triple Therapy With DAAs Gets Patients With Hepatitis C Virus to...
Firstwordpharma News
-
April 16, 2019
0
Infectious diseases
An Exclusive Look at Scynexis and Attacking Resistant C. Auris
Biospace News
-
April 11, 2019
0
Infectious diseases
Appili Therapeutics Receives Government of Canada Assistance to Support Continued Growth...
Firstwordpharma News
-
April 10, 2019
0
1
2
3
4
Page 1 of 4
- Advertisement -
MOST POPULAR
Radiofrequency Ablation Is Highly Effective in Treating Benign Thyroid Nodules: Presented...
May 20, 2019
Health Canada Approves Otsuka and Lundbeck’s REXULTI (brexpiprazole) as Adjunctive Treatment...
February 22, 2019
Salvage Radical Prostatectomy, Cryotherapy Viable Options for Recurrent Prostate Cancer: Presented...
March 21, 2019
Liquidia Technologies Presents Phase 3 Trial Data for LIQ861 at the...
April 3, 2019
Load more
HOT NEWS
Commercial
Moleculin Announces Successful Expansion of its Leukemia Drug Program
Commercial
Merck to Hold Second-Quarter 2019 Sales and Earnings Conference Call on...
Clinical
FDA clears Karyopharm’s nuclear export inhibitor Xpovio for refractory multiple myeloma
Deals
Immatics Announces Clinical Trial Collaboration in Immunotherapy for Solid Cancers
